Gilead Sciences (GILD) Preferred Stock Liabilities (2012 - 2015)

Gilead Sciences (GILD) has reported Preferred Stock Liabilities for 4 consecutive years, with $2.0 million the latest figure, recorded in Q4 2015.

• For the quarter ending Q4 2015, Preferred Stock Liabilities fell 86.67% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2015 stood at $2.0 million (down 86.67% YoY), and the FY2015 full-year result was $2.0 million, down 86.67% from the prior year.
• Preferred Stock Liabilities fell to $2.0 million in Q4 2015 per GILD's latest filing, from $4.0 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $64.0 million in Q4 2013 and bottomed at $2.0 million in Q4 2015.
• Historically, Preferred Stock Liabilities has averaged $21.9 million across 4 years, with a median of $13.0 million in 2014.
• The sharpest annual moves came in 2013 and 2015: Preferred Stock Liabilities soared 795.48% in 2013, then slumped 86.67% in 2015.
• Over 4 years, Preferred Stock Liabilities stood at $7.1 million in 2012, then soared by 795.48% to $64.0 million in 2013, then tumbled by 76.56% to $15.0 million in 2014, then plunged by 86.67% to $2.0 million in 2015.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $2.0 million, $4.0 million, and $7.0 million for Q4 2015, Q3 2015, and Q2 2015 respectively.